Table 2 Treatments and outcomes of patients (n = 24)

Treatments

 Antiviral, n (%)

14 (100)

10 (100)

1

 Glucocorticoids, n (%)

14 (100)

10 (100)

1

 Antibiotics, n (%)

9 (64)

3 (30)

0.213

 Antifungal, n (%)

6 (43)

1 (10)

0.171

 Low-flow nasal cannula, n (%)

4 (29)

7 (70)

0.095

 Mechanical ventilation, n (%)

9 (64)

3 (30)

0.214

 Extracorporeal membrane oxygenation, n (%)

1 (7)

0

1

 CP transfusion

  Low dose, n (%)

9 (69)

–

–

  High dose, n (%)

4^a (31)

–

–

  Initial transfusion time, mean ± SE, d^b

20.7 ± 3.6

–

–

Mortality

 7-day mortality, n (%)^c

1 (7)

0

1

 28-day mortality, n (%)^d

3 (21)

1 (10)

0.615

Radiological alleviation of lesions

 7-day alleviation proportion, n (%)^c

5 (36)

2 (20)

0.653

 28-day alleviation proportion, n (%)^d

12 (86)

5 (50)

0.085